HLA expression in relation to HLA type in classic Hodgkin lymphoma patients
… human leukocyte antigen (HLA) alleles are strongly associated with susceptibility to classic
Hodgkin lymphoma (cHL)… on cHL tumour cells to lose HLA expression is associated with HLA …
Hodgkin lymphoma (cHL)… on cHL tumour cells to lose HLA expression is associated with HLA …
[PDF][PDF] HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients. Cancers 2021, 13, 5833
GW Tan, P Jiang, IM Nolte, K Kushekhar, RN Veenstra… - 2021 - academia.edu
… human leukocyte antigen (HLA) alleles are strongly associated with susceptibility to classic
Hodgkin lymphoma (cHL)… on cHL tumour cells to lose HLA expression is associated with HLA …
Hodgkin lymphoma (cHL)… on cHL tumour cells to lose HLA expression is associated with HLA …
Interaction between ERAP alleles and HLA class I types support a role of antigen presentation in Hodgkin lymphoma development
P Jiang, RN Veenstra, A Seitz, IM Nolte, BG Hepkema… - Cancers, 2021 - mdpi.com
… HLA class I, ie, endoplasmic reticulum aminopeptidase 1 (ERAP1) and ERAP2. We hypothesized
that ERAP and HLA class I type … and ERAP2 expression in tumor cells and cells in the …
that ERAP and HLA class I type … and ERAP2 expression in tumor cells and cells in the …
Association of HLA diversity with the risk of 25 cancers in the UK Biobank
QL Wang, TM Wang, CM Deng, WL Zhang, YQ He… - …, 2023 - thelancet.com
… A lower risk of Hodgkin lymphoma was associated with the HLA class I … HLA diversity was
observed in the development of lung cancer, non-Hodgkin lymphoma and Hodgkin lymphoma. …
observed in the development of lung cancer, non-Hodgkin lymphoma and Hodgkin lymphoma. …
Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients
K Karihtala, SK Leivonen… - Blood …, 2022 - ashpublications.org
… course of classical Hodgkin lymphoma (cHL). We used gene … , HLA-DR expression did not
correlate with CD4 + T cell or … tissue, they can also be expressed in malignant cells. In cHL, …
correlate with CD4 + T cell or … tissue, they can also be expressed in malignant cells. In cHL, …
Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab
Y Shi, H Su, Y Song, W Jiang, X Sun, W Qian… - …, 2020 - thelancet.com
… expression levels of PD-L1, PD-L2, major histocompatibility complex (MHC) class I and class
II in tumor [ … of tumor cell turnover, which reflects real-time tumor cell mortality, rather than …
II in tumor [ … of tumor cell turnover, which reflects real-time tumor cell mortality, rather than …
Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58
J Veldman, L Visser, M Huberts-Kregel… - Blood, The Journal …, 2020 - ashpublications.org
… Hodgkin lymphoma (HL) characteristic is the tight adherence of rosetting CD4 + T cells to
Hodgkin tumor cells. … To address this, we developed a novel short-term in vitro coculture model …
Hodgkin tumor cells. … To address this, we developed a novel short-term in vitro coculture model …
Study on the inflammatory microenvironment of Epstein‒Barr virus-infected Hodgkin's lymphoma
H Li, B Li, X Li - 2024 - researchsquare.com
… expression of MHC-I on tumour cells is a prerequisite for successful anti-PD-1/PD-L1 therapy
and that the expression of MHC-… , Chinese Medical Association, Chinese Working Group for …
and that the expression of MHC-… , Chinese Medical Association, Chinese Working Group for …
Human Leucocyte Antigen (HLA) class I expression is an EBV-independent major determinator of microenvironment composition in classic Hodgkin Lymphoma and …
W Klapper, B Müller-Meinhardt, N Seifert, J Grund… - 2023 - researchsquare.com
… a T-cell immune response directed against the neoplastic cells, we investigate the immune
landscape of HL in relation to the expression of HLA … in Chinese classical Hodgkin lymphoma …
landscape of HL in relation to the expression of HLA … in Chinese classical Hodgkin lymphoma …
HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC
… expression can also benefit from immunotherapy [14, 15]. In summary, it can be found that the
PD-L1 expression level of tumor cells is … (Shanghai, China). A total of 75 NSCLC and para-…
PD-L1 expression level of tumor cells is … (Shanghai, China). A total of 75 NSCLC and para-…